NAP1L1 and hepatocellular carcinoma: In regorafenib resistant cell lines we induced, western blot assay revealed the expression of NAP1L1 and EMT-related proteins N-cadherin and Vimentin was significantly increased, whereas E-cadherin expression was decreased compared with those in sensitive cells, indicating that EMT process may promote regorafenib resistance in HCC.